Pfizer Stock at $25: A $29 Wall Street Mean Target Backed by Two Legal Wins and 22% Portfolio Growth

Pfizer Stock at $25: A $29 Wall Street Mean Target Backed by Two Legal Wins and 22% Portfolio Growth — alphai